These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 17028670)

  • 1. The roles of mucus-associated bacteria in inflammatory bowel disease.
    Zhang L; Mitchell H
    Drugs Today (Barc); 2006 Sep; 42(9):605-16. PubMed ID: 17028670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The intestinal mucus layer from patients with inflammatory bowel disease harbors high numbers of bacteria compared with controls.
    Schultsz C; Van Den Berg FM; Ten Kate FW; Tytgat GN; Dankert J
    Gastroenterology; 1999 Nov; 117(5):1089-97. PubMed ID: 10535871
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Natural Transmission of Helicobacter saguini Causes Multigenerational Inflammatory Bowel Disease in C57/129 IL-10
    Mannion A; Shen Z; Feng Y; Puglisi D; Muthupalani S; Whary MT; Fox JG
    mSphere; 2020 Mar; 5(2):. PubMed ID: 32213619
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enteric bacteria, lipopolysaccharides and related cytokines in inflammatory bowel disease: biological and clinical significance.
    Caradonna L; Amati L; Magrone T; Pellegrino NM; Jirillo E; Caccavo D
    J Endotoxin Res; 2000; 6(3):205-14. PubMed ID: 11052175
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sulfide as a Mucus Barrier-Breaker in Inflammatory Bowel Disease?
    Ijssennagger N; van der Meer R; van Mil SWC
    Trends Mol Med; 2016 Mar; 22(3):190-199. PubMed ID: 26852376
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intestinal mucus barrier in normal and inflamed colon.
    Corazziari ES
    J Pediatr Gastroenterol Nutr; 2009 Apr; 48 Suppl 2():S54-5. PubMed ID: 19300126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease.
    Takaishi H; Matsuki T; Nakazawa A; Takada T; Kado S; Asahara T; Kamada N; Sakuraba A; Yajima T; Higuchi H; Inoue N; Ogata H; Iwao Y; Nomoto K; Tanaka R; Hibi T
    Int J Med Microbiol; 2008 Jul; 298(5-6):463-72. PubMed ID: 17897884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Commensal-innate immune miscommunication in IBD pathogenesis.
    Cario E
    Dig Dis; 2012; 30(4):334-40. PubMed ID: 22796793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of Helicobacter species DNA by quantitative PCR in the gastrointestinal tract of healthy individuals and of patients with inflammatory bowel disease.
    Huijsdens XW; Linskens RK; Koppes J; Tang YL; Meuwissen SG; Vandenbroucke-Grauls CM; Savelkoul PH
    FEMS Immunol Med Microbiol; 2004 May; 41(1):79-84. PubMed ID: 15094170
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monoassociation of SCID mice with Helicobacter muridarum, but not four other enterics, provokes IBD upon receipt of T cells.
    Jiang HQ; Kushnir N; Thurnheer MC; Bos NA; Cebra JJ
    Gastroenterology; 2002 May; 122(5):1346-54. PubMed ID: 11984521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Inflammatory bowel disease: IBD].
    Endo K; Shiga H; Kinouchi Y; Shimosegawa T
    Rinsho Byori; 2009 Jun; 57(6):527-32. PubMed ID: 19621784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specific-pathogen-free conditions enhance inflammatory bowel disease in T-cell receptor knockout, but not C3H/HeJBir mice.
    Patterson MM; Schaver DB; Fox JG
    Lab Anim Sci; 1998 Oct; 48(5):432-3. PubMed ID: 10090054
    [No Abstract]   [Full Text] [Related]  

  • 13. Mucosal barrier, bacteria and inflammatory bowel disease: possibilities for therapy.
    Merga Y; Campbell BJ; Rhodes JM
    Dig Dis; 2014; 32(4):475-83. PubMed ID: 24969297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory bowel disease: the role of environmental factors.
    Danese S; Sans M; Fiocchi C
    Autoimmun Rev; 2004 Jul; 3(5):394-400. PubMed ID: 15288007
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microbiome-Epigenome Interactions and the Environmental Origins of Inflammatory Bowel Diseases.
    Fofanova TY; Petrosino JF; Kellermayer R
    J Pediatr Gastroenterol Nutr; 2016 Feb; 62(2):208-19. PubMed ID: 26308318
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Defective antibacterial barrier in inflammatory bowel disease.
    Klag T; Stange EF; Wehkamp J
    Dig Dis; 2013; 31(3-4):310-6. PubMed ID: 24246980
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bacterial flora in inflammatory bowel disease.
    Marteau P
    Dig Dis; 2009; 27 Suppl 1():99-103. PubMed ID: 20203504
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of infection in inflammatory bowel disease: initiation, exacerbation and protection.
    Lidar M; Langevitz P; Shoenfeld Y
    Isr Med Assoc J; 2009 Sep; 11(9):558-63. PubMed ID: 19960852
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic Potential to Modify the Mucus Barrier in Inflammatory Bowel Disease.
    Sun J; Shen X; Li Y; Guo Z; Zhu W; Zuo L; Zhao J; Gu L; Gong J; Li J
    Nutrients; 2016 Jan; 8(1):. PubMed ID: 26784223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.